Vasovagal Syncope

Loss of consciousness due to a reduction in blood pressure that is associated with an increase in vagal tone and peripheral vasodilation.

Also Known As:

Syncope, Vasovagal; Neurally Mediated Faint; Syncope, Cerebral; Syncope, Malignant Neurocardiogenic; Syncope, Supine; Syncope, Vasovagal, Neurally-Mediated; Cerebral Syncope; Cerebral Syncopes; Faint, Neurally Mediated; Faints, Neurally Mediated; Malignant Neurocardiogenic Syncope; Malignant Neurocardiogenic Syncopes; Neurally Mediated Faints; Neurocardiogenic Syncope; Neurocardiogenic Syncope, Malignant; Neurocardiogenic Syncopes; Neurocardiogenic Syncopes, Malignant; Neurogenic Syncope; Neurogenic Syncopes; Supine Syncope; Supine Syncopes; Syncopes, Cerebral; Syncopes, Malignant Neurocardiogenic; Syncopes, Neurocardiogenic; Syncopes, Neurogenic; Syncopes, Supine; Syncopes, Vasodepressor; Syncopes, Vasovagal; Vasodepressor Syncope; Vasodepressor Syncopes; Vasovagal Syncopes; Syncope, Neurocardiogenic; Syncope, Neurogenic; Syncope, Vasodepressor

Nervous System Diseases: 14178
- Neurologic Manifestations: 7102
  - Neurobehavioral Manifestations: 1586
    - Consciousness Disorders: 726
      - Unconsciousness: 1731
        Syncope: 4445
        Vasovagal Syncope: 663
- Autonomic Nervous System Diseases: 722
  - Primary Dysautonomias: 5
    - Orthostatic Intolerance: 381
      - Vasovagal Syncope: 663
Signs and Symptoms Pathological Conditions
- Signs and Symptoms
  - Neurologic Manifestations: 7102
    - Neurobehavioral Manifestations: 1586
      - Consciousness Disorders: 726
        Unconsciousness: 1731
        Syncope: 4445
        Vasovagal Syncope: 663

E Caraşca Selected Research

E Caraşca Research Topics

Disease

Drug/Important Bio-Agent (IBA)